Showing results for "Will Damron" in Forecasting & Strategic Planning

Brought to you by Penguin. From a former President of Tesla comes The Algorithm—the first book written by any of Elon Musk’s direct reports—a transformative guide for leaders, entrepreneurs, and innovators who want to emulate the paradigm-shattering approach Musk used to launch Tesla and...

'A fascinating and inspiring field guide for plunging into uncertainty' - Oliver Burkeman 'A powerful roadmap for a tumultuous world' - Cal Newport Master of Change offers a captivating and compelling new framework for negotiating our changing world and workplace, and going on to thrive within...

Brought to you by Penguin. Why do some ideas make it big while others fail to take off? According to award-winning behavioural economist John List, the answer comes down to a single question: Can the idea scale? Countless enterprises fall apart the moment they scale; their positive results...

Pharmaceutical companies launch new products for two fundamental reasons, new products drive growth and growth drives valuations. But consistent growth has never been harder to come by. The decreasing tenure of companies in the S&P 500 Index is an indication of this. The 33-year average tenure of companies in 1964 declined to 24 years by 2016 and is projected to shrink to just 12 years by 2027. More than ever, companies must understand the levers that accelerate growth and put their shoulders behind them.